Identification and characterization of a 30K protein (Ad4E3-30K) encoded by the E3 region of human adenovirus type 4

Virology

Volumn 273, Issue 1, 2000, Pages 127-138

  Li, Ying ^a   Wold, William S M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; GLYCAN; GLYCOSIDASE; HYBRID PROTEIN; MANNOSE; MEMBRANE PROTEIN; TUNICAMYCIN; VIRUS PROTEIN;

ARTICLE; DELETION MUTANT; GENE EXPRESSION SYSTEM; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS;

ADENOVIRIDAE; DNA VIRUSES; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 4; ORYCTOLAGUS CUNICULUS;

EID: 0034691598     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0384     Document Type: Article

References (77)

1. Anderson M., Paabo S., Nilsson T., Peterson P. A. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell. 43:1985;215-222.
2. Anderson M., McMichael A., Peterson P. A. Reduced allorecognition of adenovirus-2 infected cells. J. Immunol. 138:1987;3960-3966.
3. Babaloa O. E., Amoni S. S., Samaila E., Thaker U., Darougar S. An outbreak of acute haemorrhagic conjunctivitis in Kaduna, Nigeria. Br. J. Ophthalmol. 74:1990;89-92.
4. Barraza E. M., Ludwig S. L., Gaydos J. C., Brundage J. F. Reemergence of adenovirus type 4 acute respiratory disease in military trainees: Report of an outbreak during a lapse in vaccination. J. Infect. Dis. 179:1999;1531-1533.
5. Burgert H. G., Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell. 41:1985;987-997.
6. Burgert H. G., Maryanski J. L., Kvist S. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. USA. 84:1987;1356-1360.
7. Carlin C. R., Tollefson A. E., Brady H. A., Hoffman B. L., Wold W. S. M. Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell. 57:1989;135-144.
8. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
9. Chengalvala M. V., Lubeck M. D., Selling B. J., Natuk R. J., Hsu K. H., Mason B. B., Chanda K. K., Bhat R. A., Bhat B. M., Mizutani S. Adenovirus vectors for gene expression. Curr. Opin. Biotechnol. 2:1991a;718-722.
10. Chengalvala M., Lubeck M. D., Davis A. R., Mizutani S., Molnar-Kimber K., Morin J., Hung P. P. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine. 9:1991b;485-490.
11. Chengalvala M. V., Bhat B. M., Bhat R., Lubeck M. D., Mizutani S., Davis A. R., Hung P. P. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. J. Gen. Virol. 75:1994;125-131.
12. Chengalvala M. V., Bhat B. M., Bhat R. A., Dheer S. K., Lubeck M. D. Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Vaccine. 15:1997;335-339.
13. Dudding B. A., Top F. H. Jr., Scott R. M., Russell P. K., Buescher E. L. An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines. Am. J. Epidemiol. 95:1972;140-147.
14. Elsing A., Burgert H. G. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc. Natl. Acad. Sci. USA. 95:1998;10072-10077.
15. Fuerst T. R., Niles E. G., Studier F. W. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
16. Gooding L. R., Elmore L. W., Tollefson A. E., Brady H. A., Wold W. S. M. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell. 53:1988;341-346.
17. Gooding L. R., Sofola I. O., Tollefson A. E., Duerksen-Hughes P., Wold W. S. M. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J. Immunol. 145:1990;3080-3086.
18. Gooding L. R., Ranheim T. S., Tollefson A. E., Aquino L., Duerksen-Hughes P., Horton T. M., Wold W. S. M. The 10,400- and 14,500-Dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65:1991;4114-4123.
19. Graham F. L., Van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
20. Gruber W. C., Russell D. J., Tibbetts C. Fiber gene and genomic origin of human adenovirus type 4. Virology. 196:1993;603-611.
21. Hawkins L. K., Wold W. S. M. A 12,500 MW protein is coded by region E3 of adenovirus. Virology. 188:1992;486-494.
22. Hawkins L. K., Wold W. S. M. A 20,500-dalton protein is coded by region E3 of subgroup B but not subgroup C human adenoviruses. Virology. 208:1995a;226-233.
23. Hawkins L. K., Wold W. S. M. The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides. Virology. 210:1995b;335-344.
24. Hawkins L. K., Wilson-Rawls J., Wold W. S. M. Region E3 of subgroup B human adenoviruses encodes a 16-kilodalton membrane protein that may be a distant analog of the E3-6.7K protein of subgroup C adenoviruses. J. Virol. 65:1995;4292-4298.
25. Horton T. M., Tollefson A. E., Wold W. S. M., Gooding L. R. A Protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes. J. Virol. 64:1990;1250-1255.
26. Horton T. M., Ranheim T. S., Aquino L., Kusher D. I., Saha S. K., Ware C. F. Adenovirus E3-14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J. Virol. 65:1991;2629-2639.
27. Horwitz M. S. Adenovirus. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;2149-2171 Lippincott-Raven, Philadelphia.
28. Hsu K. H., Lubeck M. D., Davis A. R., Bhat R. A., Selling B. H., Bhat B. M., Mizutani S., Murphy B. R., Collins P. L., Chanock R. M. Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee. J. Infect. Dis. 166:1992;769-775.
29. Hsu K. H., Lubeck M. D., Bhat B. M., Bhat R. A., Kostek B., Selling B. H., Mizutani S., Davis A. R., Hung P. P. Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine. 12:1994;607-612.
30. Jackson M. R., Nilsson T., Peterson P. A. Retrieval of transmembrane proteins to the endoplasmic reticulum. J. Cell. Biol. 121:1993;317-333.
31. Kaufman R. J., Davies M. V., Pathak V. K., Hershey J. W. B. The phosphorylation state of eukaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol. Cell. Biol. 9:1989;946-958.
32. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:1985;631-664.
33. Krajcsi P., Dimitrov T., Hermiston T. W., Tollefson A. E., Ranheim T. S., Vande Pol S. B., Stephenson A. H., Wold W. S. M. The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J. Virol. 70:1996;4904-4913.
34. Kvist S., Ostberg L., Persson H., Philipson L., Peterson P. A. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc. Natl. Acad. Sci. USA. 75:1978;5674-5678.
35. Levandowski R. A., Rubenis M. Nosocomial conjunctivitis caused by adenovirus type 4. J. Infect. Dis. 143:1981;28-31.
36. Levin S., Dietrich J., Guillory J. Fatal nonbacterial pneumonia associated with adenovirus type 4 occurrence in an adult. J. Am. Med. Assoc. 201:1967;975-977.
37. Li Y., Kang J., Horwitz M. Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers. J. Virol. 71:1997;1576-1582.
38. Li Y., Kang J., Horwitz M. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol. Cell. Biol. 18:1998;1601-1610.
39. Li Y., Kang J., Friedman J., Tarassishin L., Ye J., Kovalenko A., Wallach D., Horwitz M. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis. Proc. Natl. Acad. Sci. USA. 96:1999;1042-1047.
40. Lubeck M. D., Natuk R. J., Chengalvala M., Chansa P. K., Murthy K. K., Murthy S., Mizutani S., Lee S. G., Wade M. S., Bhat B. M. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retroviruses. 10:1995;1443-1449.
41. Mahr J., Gooding L. R. Immune evasion by adenoviruses. Immunol. Rev. 168:1999;121-130.
42. Muzzi A., Rocchi G., Lumbroso B., Tosato G., Barbieri F. Acute haemorrhagic conjunctivitis during an epidemic outbreak of adenovirus-type-4 infection. Lancet. 2:1975;822-823.
43. Natuk R. J., Chanda P. K., Lubeck M. D., Davis A. R., Wilhelm J., Hjorth R., Wade M. S., Bhat B. M., Mizutani S., Lee S. Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog. Proc. Natl. Acad. Sci. USA. 89:1992;7771-7781.
44. Natuk R. J., Davis A. R., Chanda P. K., Lubeck M. D., Chengalvala M., Murthy S. C., Wade M. S., Dheer S. K., Bhat B. M., Murthy K. K. Adenovirus vectored vaccines. Dev. Biol. Stand. 82:1994;71-77.
45. Natuk R. J., Wade M. S., Chengalvala M., Murthy K. K., Chansa P. K., Murthy S. C., Bhat B. M., Bhat R., Dheer S. K., Mizutani S. Adenovirus as a vector for HIV: Efficacy and safety issues. Dev. Biol. Stand. 84:1995;153-156.
46. Paabo S., Weber F., Kampe O., Schaffner W., Peterson P. A. Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector. Cell. 33:1983;445-453.
47. Rosenvaum M. J., De Berry P., Sullivan E. J., Edwards E. A., Pierce W. E., Muldoon R. L., Jackson G. G., Peckinpaugh R. O. Characteristics of vaccine-induced and natural infection with adenovirus type 4 in naval recruits. Am. J. Epidermiol. 88:1968;45-54.
48. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
49. Scaria A., Tollefson A. E., Saha S., Wold W. S. M. The E3-11.6K protein of adenovirus is an Asn-glycosylated integral membrane protein that localizes to the nuclear membrane. Virology. 191:1992;743-753.
50. Schepetiuk S. K., Norton R., Kok T., Irving L. G. Outbreak of adenovirus type 4 conjunctivitis in South Australia. J. Med. Virol. 41:1993;316-318.
51. Shenk T. Adenoviridae: The viruses and their replication. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;2111-2148 Lippincott-Raven, Philadelphia.
52. Shisler J., Yang C., Walter B., Ware C. F., Wold W. S. M. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71:1997;8299-8306.
53. Sonoguchi T., Fukumi H. Causes of common cold in new recruits, with reference to the significance of adenovirus type-4. Nippon Ishikai Zasshi [J. Jpn. Med. Assoc.]. 57:1967;1540-1542.
54. Stewart A. R., Tollefson A. E., Krajcsi P., Yei S., Wold W. S. M. The adenovirus E3-10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. J. Virol. 69:1995;172-181.
55. Tollefson A. E., Stewart A. R., Yei S., Saha A. K., Wold W. S. M. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J. Virol. 65:1991;3095-3105.
56. w protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stage of infection. J. Virol. 66:1992;3633-3642.
57. Tollefson A. E., Scaria A., Hermiston T. W., Ryerse J. S., Wold W. S. M. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70:1996a;2296-2306.
58. Tollefson A. E., Ryerse J. S., Scaria A., Hermiston T. W., Wold W. S. M. The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: Characterization of cells infected with adp mutants. Virology. 220:1996b;152-162.
59. Tollefson A., Hermiston T. W., Lichtenstein D. L., Colle C. F., Tripp R. A., Dimitrov T., Toth K., Wells C. E., Doherty P. C., Wold W. S. M. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature. 392:1998;727-730.
60. Tollefson A., Hermiston T. W., Wold W. S. M. Preparation and titration of CsCl-banded adenovirus stock. Wold W. S. M. Adenovirus Methods and Protocols. 1999;1-10 Humana Press, Clifton.
61. Top F. H. Jr. Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J. Biol. Med. 48:1975;185-195.
62. Top F. H. Jr., Grossman R. A., Bartelloni P. J., Segal H. E., Dudding B. A., Russell P. K., Buscher E. L. Immunization with live type 7 and 4 adenovirus vaccine in humans. J. Infect. Dis. 124:1971;148-154.
63. Tsuki-Wang L., Aoki K., Isobe K., Shiao S., Toba K., Kobayashi N., Noguchi Y., Ohno S. Genome analysis of adenovirus type 4 strains isolated from acute conjunctivitis in Japan. Jpn. J. Ophthalmol. 41:1997;308-311.
64. Tullo A. B., Higgins P. G. An outbreak of adenovirus type 4 conjunctivitis. Br. J. Ophthalmol. 64:1980;489-493.
65. Voelkel-Johnson C., Entingh A. J., Wold W. S. M., Gooding L. R., Laster S. M. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J. Immunol. 154:1995;1707-1716.
66. Wilson-Rawls J., Deutscher S. L., Wold W. S. M. The signal-anchor domain of adenovirus E3-6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum. Virology. 201:1994;66-76.
67. Wilson-Rawls J., Saha S. K., Krajcsi P., Tollefson A. E., Gooding L. R., Wold W. S. M. A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2. Virology. 178:1990;204-212.
68. Wilson-Rawls J., Wold W. S. M. The E3-6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum. Virology. 195:1993;6-15.
69. Wold W. S. M., Gooding L. R. Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology. 184:1991;1-8.
70. Wold W. S. M., Hermiston T. W., Tollefson A. E. Strategies of immune modulation by adenoviruses. McFadden G. Viroreceptors, Virokines, and Related Mechanisms of Immune Modulation by DNA Viruses. 1995a;145-183 R. G. Landes, Austin.
71. Wold W. S. M., Hermiston T. W., Tollefson A. E. Functions of the adenovirus E3 proteins. Curr. Top. Microbiol. Immunol. 199:1995b;237-274.
72. Wold W. S. M., Tollefson A. E., Hermiston T. W. E3 transcription unit of adenovirus. Doerfler W., Bohm P. The Molecular Repertoire of Adenoviruses. 1995c;237-274 Springer-Verlag, Heidelberg.
73. Wold W. S. M., Tollefson A. E. Adenovirus E3 proteins: 14.7K, RID, and gp19K inhibit immune-induced cell death; Adenovirus death protein promotes cell death. Semin. Virol. 8:1998;515-523.
74. Wold W. S. M., Tollefson A. E. Adenovirus-host interactions to subvert the host immune system. Seth P. Adenoviruses: Basic Biology to Gene Therapy. 1999;245-252 R. G. Landes, Austin.
75. Wold W. S. M., Toth K., Doronin K., Kuppuswamy M., Lichtenstein D. L., Tollefson A. E. Adenovirus inhibition of immune-mediated apoptosis. Clin. Immunol. Newslett. 19:1999a;1-7.
76. Wold W. S. M., Doronin K., Toth K., Kuppuswamy M., Lichtenstein D. L., Tollefson A. E. Immune responses to adenoviruses: Viral evasion mechanisms and their implications for the clinic. Curr. Opin. Immunol. 11:1999b;380-386.
77. Zilli D., Voelkel-Johnson C., Skinner T., Laster S. M. The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid. Biochem. Biophys. Res. Commun. 188:1992;177-183.